Article
Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Mar 2005
Nuesch Reto, Ananworanich Jintanat, Sirivichayakul Sunee, Ubolyam Sasiwimol, Siangphoe Umaporn, Hill Andrew, Cooper David, Lange Joep, Phanuphak Praphan, Ruxrungtham Kiat
Abstract excerpt
BACKGROUND: For patients with human immunodeficiency virus (HIV) infection, structured treatment interruption (STI) is an attractive alternative strategy to continuous treatment, particularly in resource-restrained settings, because it reduces both side effects and costs. One major concern, however, is the development of resistance to antiretroviral drugs that can occur during multiple cycles of starting and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.